NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.40 +0.03 (+8.68%) As of 06/27/2025 02:53 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Biotricity Stock (NASDAQ:BTCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotricity alerts:Sign Up Key Stats Today's Range$0.35▼$0.4450-Day Range$0.37▼$0.5852-Week Range$0.19▼$1.01Volume1,086 shsAverage Volume36,810 shsMarket Capitalization$10.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More… Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address BTCY Stock News HeadlinesBiotricity, Inc. (BTCY) - Yahoo FinanceJune 26 at 1:17 PM | finance.yahoo.comBiotricity (BTCY) to Release Quarterly Earnings on WednesdayJune 23, 2025 | americanbankingnews.com"I'm risking my reputation on this"What the headlines won't tell you: Smart money was positioned before both events. They didn't react to news—they anticipated it. How? They follow patterns. Market cycles. Institutional flows. The same patterns we document in Crypto Revolution and the next pattern is forming now. | Crypto 101 Media (Ad)Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedApril 8, 2025 | markets.businessinsider.comBiotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period AnalyzedApril 8, 2025 | globenewswire.comBiotricity expands intellectual property portfolio with 14 new patentsMarch 12, 2025 | msn.comBiotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease ManagementMarch 12, 2025 | globenewswire.comBiotricity Inc (BTCY) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ...February 22, 2025 | finance.yahoo.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $0.2899 at the beginning of the year. Since then, BTCY stock has increased by 38.7% and is now trading at $0.4021. View the best growth stocks for 2025 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) released its quarterly earnings results on Thursday, June, 27th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.11. The business had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an initial public offering (IPO) on Thursday, August 26th 2021. The company issued 5,000,000 shares at $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Transdigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL). Company Calendar Last Earnings6/27/2024Today6/27/2025Next Earnings (Estimated)8/18/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BTCY CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.09 million Net Margins-80.42% Pretax Margin-80.42% Return on EquityN/A Return on Assets-188.47% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.10 Sales & Book Value Annual Sales$12.06 million Price / Sales0.83 Cash FlowN/A Price / Cash FlowN/A Book Value($1.30) per share Price / Book-0.31Miscellaneous Outstanding Shares24,912,000Free Float22,075,000Market Cap$10.02 million OptionableOptionable Beta1.21 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:BTCY) was last updated on 6/28/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStargate could destroy Chinese AIStargate is a massive, $500 billion SuperProject involving Microsoft, Nvidia, OpenAI and Oracle, among countle...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.